Largest pharmaceutical companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Spyre Therapeutics has the lowest figure of the 52 pharmaceutical companies ranked by revenue, at NOK 0, followed by Praxis Precision Medicines (NOK 0) and Dianthus Therapeutics (NOK 19.7M). Figures as of 18 Nov 2026, 22:22 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- Lowest
- Spyre TherapeuticsNOK 0
- Median
- NOK 31B
- Combined market value
- NOK 48.97T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Spyre TherapeuticsSYRE · Health Care | NOK 0 | NOK 93.3B | NOK 982.10 | 8.15% up | 286% up | ||
| 2 | Praxis Precision MedicinesPRAX · Health Care | NOK 0 | NOK 82.6B | NOK 2,954.14 | 0.04% up | 61% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | NOK 19.7M | NOK 45.8B | NOK 812.90 | 3.45% down | 113% up | ||
| 4 | Roivant SciencesROIV · Health Care | NOK 80M | NOK 271.6B | NOK 374.89 | 0.05% up | 90% up | ||
| 5 | Protagonist TherapeuticsPTGX · Health Care | NOK 445.4M | NOK 80.3B | NOK 1,230.87 | 2.00% up | 46% up | ||
| 6 | CytokineticsCYTK · Health Care | NOK 852.2M | NOK 69.2B | NOK 496.76 | 0.64% down | 20% down | ||
| 7 | Rhythm PharmaceuticalsRYTM · Health Care | NOK 1.8B | NOK 79.9B | NOK 1,152.27 | 2.08% up | 13% up | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | NOK 2.6B | NOK 57.8B | NOK 2,891.41 | 1.67% up | 43% up | ||
| 9 | Travere TherapeuticsTVTX · Health Care | NOK 4.8B | NOK 46.7B | NOK 486.31 | 1.68% down | 44% up | ||
| 10 | BridgeBio PharmaBBIO · Health Care | NOK 4.9B | NOK 147.1B | NOK 755.11 | 1.58% up | 17% up | ||
| 11 | Mirum PharmaceuticalsMIRM · Health Care | NOK 5B | NOK 58.4B | NOK 895.27 | 0.59% up | 31% up | ||
| 12 | InsmedINSM · Health Care | NOK 5.9B | NOK 254.4B | NOK 1,159.62 | 1.69% down | 40% down | ||
| 13 | TG TherapeuticsTGTX · Health Care | NOK 6B | NOK 96.7B | NOK 640.02 | 5.44% up | 107% up | ||
| 14 | Axsome TherapeuticsAXSM · Health Care | NOK 6.2B | NOK 68.2B | NOK 1,297.07 | 1.43% down | 7% down | ||
| 15 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | NOK 6.6B | NOK 72.3B | NOK 920.05 | 0.06% down | 126% up | ||
| 16 | Corcept TherapeuticsCORT · Health Care | NOK 7.4B | NOK 71.8B | NOK 656.18 | 3.25% down | 8% down | ||
| 17 | Ascendis PharmaASND · Health Care | NOK 7.7B | NOK 171.6B | NOK 2,616.70 | 0.32% down | 28% up | ||
| 18 | Arrowhead PharmaceuticalsARWR · Health Care | NOK 8B | NOK 59B | NOK 417.29 | 0.28% up | 10% up | ||
| 19 | Ionis PharmaceuticalsIONS · Health Care | NOK 9.1B | NOK 44.2B | NOK 265.13 | 1.59% up | 64% down | ||
| 20 | Madrigal PharmaceuticalsMDGL · Health Care | NOK 9.3B | NOK 89.5B | NOK 3,853.28 | 5.67% down | 24% down | ||
| 21 | Legend BiotechLEGN · Health Care | NOK 10B | NOK 30.5B | NOK 157.29 | 0.87% up | 42% down | ||
| 22 | AlkermesALKS · Health Care | NOK 14.3B | NOK 76.2B | NOK 453.49 | 3.08% up | 58% up | ||
| 23 | PTC TherapeuticsPTCT · Health Care | NOK 16.8B | NOK 48.7B | NOK 583.01 | 0.22% down | 20% down | ||
| 24 | Royalty PharmaRPRX · Health Care | NOK 23B | NOK 382.2B | NOK 664.70 | 0.01% down | 78% up | ||
| 25 | Amneal PharmaceuticalsAMRX · Health Care | NOK 29.2B | NOK 73.8B | NOK 211.79 | 3.60% up | 83% up | ||
| 26 | United TherapeuticsUTHR · Health Care | NOK 30.8B | NOK 238B | NOK 5,588.45 | 1.16% down | 23% up | ||
| 27 | BioMarin PharmaceuticalBMRN · Health Care | NOK 31.2B | NOK 115.2B | NOK 594.62 | 4.99% up | 11% up | ||
| 28 | Dr. Reddy's LaboratoriesRDY · Health Care | NOK 34.6B | NOK 120.9B | NOK 145.00 | 1.28% up | 5% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | NOK 35.9B | NOK 193.7B | NOK 1,446.14 | 4.54% down | 66% down | ||
| 30 | GenmabGMAB · Health Care | NOK 36B | NOK 304.2B | NOK 493.37 | 1.91% down | 70% up | ||
| 31 | Jazz PharmaceuticalsJAZZ · Health Care | NOK 41.3B | NOK 153.9B | NOK 2,398.33 | 2.93% up | 37% up | ||
| 32 | Elanco Animal HealthELAN · Health Care | NOK 45.6B | NOK 129.2B | NOK 258.45 | 3.29% up | 20% up | ||
| 33 | BeOne MedicinesONC · Health Care | NOK 51.7B | NOK 446.2B | NOK 3,906.71 | 2.34% down | 17% up | ||
| 34 | GrifolsGRFS · Health Care | NOK 80.8B | NOK 55.8B | NOK 81.99 | 1.85% down | 1% up | ||
| 35 | ZoetisZTS · Health Care | NOK 91.6B | NOK 336.5B | NOK 828.29 | 2.50% up | 29% down | ||
| 36 | Vertex PharmaceuticalsVRTX · Health Care | NOK 116.2B | NOK 1.32T | NOK 5,192.65 | 0.42% up | 27% up | ||
| 37 | ViatrisVTRS · Health Care | NOK 138.4B | NOK 225.1B | NOK 196.30 | 0.83% down | 96% up | ||
| 38 | Regeneron PharmaceuticalsREGN · Health Care | NOK 138.8B | NOK 946.8B | NOK 9,152.41 | 1.28% down | 36% up | ||
| 39 | Teva Pharmaceutical IndustriesTEVA · Health Care | NOK 167.1B | NOK 477B | NOK 408.77 | 0.92% down | 74% up | ||
| 40 | Takeda PharmaceuticalTAK · Health Care | NOK 273.1B | NOK 657.8B | NOK 205.89 | 1.71% down | 54% up | ||
| 41 | GSKGSK · Health Care | NOK 419.7B | NOK 942.6B | NOK 470.24 | 1.34% down | 6% up | ||
| 42 | Abbott LaboratoriesABT · Health Care | NOK 429.1B | NOK 1.75T | NOK 1,011.33 | 0.22% down | 17% down | ||
| 43 | Novo NordiskNVO · Health Care | NOK 444B | NOK 1.68T | NOK 381.67 | 3.12% down | 17% down | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | NOK 466.5B | NOK 1.18T | NOK 576.52 | 2.92% down | 34% up | ||
| 45 | SanofiSNY · Health Care | NOK 468.5B | NOK 1.1T | NOK 456.11 | 0.86% down | 4% down | ||
| 46 | NovartisNVS · Health Care | NOK 527.9B | NOK 2.84T | NOK 1,502.38 | 2.46% down | 25% up | ||
| 47 | AstraZenecaAZN · Health Care | NOK 568.6B | NOK 2.68T | NOK 1,730.34 | 1.93% down | 2% up | ||
| 48 | AbbVieABBV · Health Care | NOK 592B | NOK 4.89T | NOK 2,768.48 | 2.33% down | 26% up | ||
| 49 | PfizerPFE · Health Care | NOK 605.7B | NOK 1.55T | NOK 271.61 | 1.44% down | 14% up | ||
| 50 | Merck & CoMRK · Health Care | NOK 629.3B | NOK 3.29T | NOK 1,333.66 | 3.90% down | 51% up | ||
| 51 | Eli LillyLLY · Health Care | NOK 630.9B | NOK 11.92T | NOK 13,384.55 | 2.32% down | 35% up | ||
| 52 | Johnson & JohnsonJNJ · Health Care | NOK 911.8B | NOK 6.35T | NOK 2,639.64 | 2.15% down | 38% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6797 NOK). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceutical companies have the lowest revenue?
Spyre Therapeutics (NOK 0), Praxis Precision Medicines (NOK 0) and Dianthus Therapeutics (NOK 19.7M) have the lowest revenue of the 52 pharmaceutical companies ranked here as of 18 Nov 2026, 22:22 UTC.
How many pharmaceutical companies are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceutical companies worth together?
The 52 pharmaceutical companies ranked by revenue have a combined market value of NOK 48.97T as of 18 Nov 2026, 22:22 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by revenue”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.